No abstract available
Keywords:
AML; drug resistance; eIF4E; phase I; ribavirin.
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / metabolism*
-
Cytarabine / administration & dosage
-
Drug Resistance, Neoplasm / drug effects*
-
Eukaryotic Initiation Factor-4E / metabolism*
-
Female
-
Follow-Up Studies
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / metabolism
-
Leukemia, Myeloid, Acute / pathology
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / metabolism
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Staging
-
Prognosis
-
Ribavirin / administration & dosage
-
Salvage Therapy*
-
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
-
Young Adult
Substances
-
Biomarkers, Tumor
-
Eukaryotic Initiation Factor-4E
-
Cytarabine
-
Ribavirin